Cambrex is a leading CDMO that provides comprehensive development and manufacturing solutions for small-molecule therapeutics.
Description
Cambrex is a leading global contract development and manufacturing organisation (CDMO) specialising in small molecule drug development and manufacturing.
Cambrex supports pharmaceutical innovators from development through commercialisation, offering a full spectrum of services for drug substance, drug product, and analytical testing. With facilities across North America and Europe, the company provides tailored solutions that emphasise scientific expertise, operational flexibility, and regulatory compliance.
Key Products and Services
- Drug Substance Development and Manufacturing: Small molecule APIs, process development, and scale-up.
- Drug Product Services: Oral solids, sterile injectables, and complex formulations.
- Analytical Services: Method development, validation, and stability testing.
- Specialised Capabilities: Controlled substances, high-potency APIs, and continuous flow processing.
With over 40 years of industry experience, Cambrex continues to drive innovation and excellence in pharmaceutical manufacturing, making it a trusted partner for pharmaceutical companies worldwide.
As a prominent player in the pharmaceutical industry, Cambrex continues to provide innovative solutions and manufacturing capabilities to its clients. For more information, please visit cambrex.com.
Certification
United States FDA, Canada Health Canada, Europe EMA, Denmark DKMA, India CDSCO, South Korea MFDS, UK MHRA, Sweden MPA, Brazil ANVISA, Italy AIFA
Manufacturing Information
Facilities
14
Drug Type
Small Molecule
Capabilities
- Accelerated Stability Studies
- Analytical Services
- APIs (Active Pharmaceutical Ingredients)
- Assay Development
- Biocatalysis
- Blending
- Blister
- Capsule
- cGMP Synthesis
- Chemistry (CMC)
- Chromatography
- Cleaning Equipment
- Clinical Dose
- Clinical Packaging
- Clinical Trial Materials
- Clinical Trials
- Containment
- Contract Development and Manufacturing (CDMO)
- Contract Packaging
- Controlled Release
- Controlled Substances
- Creams & Ointments
- Custom Synthesis
- Dissolution Testing
- Dosage Form Development
- Dose Form
- Drug Development
- Encapsulation
- Ethical
- Excipients
- Feasibility Studies
- Filling
- Fine Chemicals
- Fluid Bed Processing
- Forced Degradation Studies
- Formulation Development
- Gels
- Generics
- Granulation
- High Containment Operations
- High Potency
- Hot Melt Extrusion
- ICH
- Liquids
- Microencapsulation
- Micronization
- Non Sterile Dosage
- Ophthalmics
- Oral Drug Delivery
- Packaging
- Particle Size Analysis
- Powders
- Preclinical Testing
- Preformulation
- Process Analytical Technology (PAT)
- Process Development
- Process Validation Studies
- Regulatory Services
- Research & Development
- Samples
- Scale-Up
- Semisolids
- Size Reduction
- Solid Dosage
- Solutions & Suspensions
- Stability Studies
- Sterile
- Suppositories
- Sustained Release
- Tablet Coating
- Tablets
- Technology Transfer
- Topicals
- Unit Dosage
- Validation
Contact Information
Website
Twitter (X)
Address
One Meadowlands Plaza , 07073 , East Rutherford , NJ, United States
Zip/Post Code
7073
Facility Locations
United States, Germany, Estonia, Sweden, Italy, United Kingdom